Free tool

Stocks far below their 52-week high

We cover 26 companies trading at least 50% below their own 52-week high. The median market value in the group is $291.19M. Across the group, the median move over the past trading day is −1.17%. 4% of the 24 with a 200-day average trade above it. Price change over the past year runs from −56.5% to +73.9% across the middle 80 percent of the group, with a median of −37.6%.

Other lists in this group

Table

26 of 4,095 companies match these filters.Clear filters

TickerCompanyMarket cap (USD)Size1Y return
COH.AXCochlear Limited$6.39BMid cap−53.79%
4506.TSumitomo Pharma Co., Ltd.$4.05BMid cap−3.59%
EBO.AXEBOS Group Limited$2.60BMid cap−37.83%
4DX.AX4DMedical Limited$1.59BSmall cap+669.79%
CU6.AXClarity Pharmaceuticals Ltd$628.73MSmall cap−25.63%
019175.KSShinpoong Pharmaceutical Co.,Ltd$517.68MSmall cap−40.58%
4592.TSanBio Company Limited$495.75MSmall cap−57.08%
317450.KSMYUNGIN PHARM$482.84MSmall cap−55.96%
249420.KSIldong Pharmaceutical Co., Ltd.$329.08MSmall cap−40.38%
RAC.AXRacura Oncology Ltd$312.81MSmall cap+87.39%
4894.TCuorips Inc.$300.07MSmall cap−15.38%
003000.KSBukwang Pharmaceutical Co., Ltd.$294.43MSmall cap+26.14%
0120G0.KSSamyang Biopharm$292.45MSmall cap+79.14%
7777.T3-D Matrix, Ltd.$289.93MSmall cap+68.69%
950210.KSPrestige BioPharma Limited$268.90MSmall cap−55.91%
4593.THealios K.K.$239.21MSmall cap−41.63%
HLS.AXHealius Limited$233.27MSmall cap−50.55%
MYX.AXMayne Pharma Group Limited$182.17MSmall cap−37.38%
PGC.AXParagon Care Limited$166.54MSmall cap−58.24%
504A.TInnovacell Inc.$162.36MSmall cap−45.71%
EBR.AXEBR Systems, Inc.$154.30MSmall cap−78.74%
003520.KSYungjin Pharm. Co., Ltd.$150.88MSmall cap−43.89%
OCC.AXOrthocell Limited$148.74MSmall cap−36.67%
004310.KSHyundai Pharmaceutical Co., Ltd.$135.03MSmall cap+51.26%
DXB.AXDimerix Limited$122.97MSmall cap−34.83%
ONE.AXOneview Healthcare PLC$120.16MSmall cap−15.56%

Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.

More ways to browse